BARCLAYS PLC - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 137 filers reported holding TRILLIUM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.4%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$6,857,000
+5614.2%
390,496
+3055.0%
0.00%
Q2 2021$120,000
+252.9%
12,377
+291.3%
0.00%
Q1 2021$34,000
+1033.3%
3,163
+1505.6%
0.00%
Q4 2020$3,000
-99.9%
197
-99.9%
0.00%
-100.0%
Q3 2020$4,964,000
+26.7%
349,300
-27.9%
0.00%0.0%
Q2 2020$3,917,000
+639.1%
484,239
+269.2%
0.00%
Q1 2020$530,000
+597.4%
131,170
+1149.2%
0.00%
Q4 2017$76,00010,5000.00%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
NEA Management Company, LLC 2,100,000$646,0000.05%
Matrix Capital Management Company, LP 2,288,560$704,0000.02%
Tekla Capital Management LLC 446,099$137,0000.01%
Realta Investment Advisors 26,000$7,0000.00%
Virtu Financial LLC 34,991$11,0000.00%
Baker Brothers Advisors 505,262$155,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 20,044$6,0000.00%
MORGAN STANLEY 1,160,098$356,0000.00%
BANK OF MONTREAL /CAN/ 18,333$6,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 102,725$31,0000.00%
View complete list of TRILLIUM THERAPEUTICS INC shareholders